Clinical Trials Browser

Phase 2/3 × Liver Neoplasms × 90 days × Clear all

NCT05153785 2026-01-15

Perioperative Intravenous Lidocaine in Liver Surgery

Phase 2/3 Completed

Gastrointestinal

Liver Neoplasms, Pain, Postoperative